SCHEMBL5755518

SCHEMBL5755518

CCOn1ccnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3806101 0.77 CYP19A1 (0.42)
SCHEMBL2597422 0.73
SCHEMBL2842046 0.72
SCHEMBL9593308 0.71 NOTUM (0.30)
Water SCHEMBL14636839 0.69
SCHEMBL27669704 0.69 ALDH1A1 (0.32)
SCHEMBL25373636 0.68
SCHEMBL28104763 0.67
Hydrochloric Acid SCHEMBL28226758 0.65
SCHEMBL28317338 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0126430-B1 PROCESS FOR THE PREPARATION OF 1-TRIAZOLYLETHYLETHER-DERIVATIVES, AND MICROBICIDAL COMPOSITIONS CONTAINING NOVEL 1-TRIAZOLYL-PHENOXYPHENYLETHYLETHER-DERIVATIVES AS ACTIVE INGREDIENTS AND THEIR USE CIBA-GEIGY AG (CH) 1991-08-28 EP claimed
US-11358957-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2022-06-14 US disclosed
CN-108003153-B Nitrogen-containing five-membered heterocyclic quinoline compound and salt, preparation method, pharmaceutical composition and application thereof 中国医学科学院肿瘤医院 2021-04-30 CN disclosed
US-20200277287-A1 MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-09-03 US disclosed
CN-108003153-A Nitrogenous five-ring heterocycles and quinolines and its salt, preparation method, pharmaceutical composition and purposes 中国医学科学院肿瘤医院 2018-05-08 CN disclosed
US-20160002179-A1 SUBSTITUTED IMIDAZOLE AND (1,2,4)TRIAZOLE COMPOUNDS AS FUNGICIDES BASF SE (DE) 2016-01-07 US disclosed
EP-2943472-A2 SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS BASF SE (DE) 2015-11-18 EP disclosed
US-20150313229-A1 Substituted [1,2,4] Triazole Compounds BASF SE (DE) 2015-11-05 US disclosed
US-20150284344-A1 Substituted [1,2,4]triazole Compounds BASF SE (DE) 2015-10-08 US disclosed
EP-2925732-A1 SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS BASF SE (DE) 2015-10-07 EP disclosed
WO-2014082879-A1 SUBSTITUTED [1,2,4]TRIAZOLE COMPOUNDS BASF SE (DE) 2014-06-05 WO disclosed
WO-2014082880-A1 SUBSTITUTED [1,2,4] TRIAZOLE COMPOUNDS BASF SE (DE) 2014-06-05 WO disclosed
EP-0915856-A4 DIPHENYL HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2006-04-12 EP disclosed
US-6271249-B1 Diphenyl imidazoles as potassium channel modulators BRISTOL-MYERS SQUIBB COMPANY 2001-08-07 US disclosed
US-6077861-A MODULATORS OF THE LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM (BK) CHANNELS, THEREFORE, USEFUL IN THE TREATMENT OF ISCHEMIC STROKE BRISTOL-MYERS SQUIBB COMPANY (US) 2000-06-20 US disclosed
EP-0915856-A1 DIPHENYL HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS Bristol-Myers Squibb Company (US) 1999-05-19 EP disclosed
US-5869509-A TREAT DISORDERS RESPONSIVE TO OPENERS OF THE LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-02-09 US disclosed
WO-1998004135-A1 DIPHENYL HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-02-05 WO disclosed
EP-0126430-B1 PROCESS FOR THE PREPARATION OF 1-TRIAZOLYLETHYLETHER-DERIVATIVES, AND MICROBICIDAL COMPOSITIONS CONTAINING NOVEL 1-TRIAZOLYL-PHENOXYPHENYLETHYLETHER-DERIVATIVES AS ACTIVE INGREDIENTS AND THEIR USE CIBA-GEIGY AG (CH) 1991-08-28 EP disclosed
EP-0126430-A2 Process for the preparation of 1-triazolylethylether-derivatives, and microbicidal compositions containing novel 1-triazolyl-phenoxyphenylethylether-derivatives as active ingredients and their use CIBA-GEIGY AG (CH) 1984-11-28 EP disclosed